Mark Brosius Sells 215 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 215 shares of the firm's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $552.07, for a total value of $118,695.05. Following the sale, the senior vice president now directly owns 1,338 shares in the company, valued at approximately $738,669.66. This trade represents a 13.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Mark Brosius also recently made the following trade(s):

• On Friday, June 6th, Mark Brosius sold 216 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.11, for a total value of $121,631.76.
• On Monday, June 2nd, Mark Brosius sold 215 shares of Intuitive Surgical stock. The shares were sold at an average price of $549.06, for a total value of $118,047.90.
• On Friday, May 16th, Mark Brosius sold 20 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.81, for a total value of $11,276.20.
• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.00, for a total value of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total value of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The stock was sold at an average price of $533.18, for a total value of $260,725.02.

Intuitive Surgical Stock Down 0.2%

ISRG stock traded down $0.98 during mid-day trading on Friday, reaching $557.08. 1,103,774 shares of the company traded hands, compared to its average volume of 1,643,591. The stock has a market cap of $199.67 billion, a price-to-earnings ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a fifty-two week low of $413.52 and a fifty-two week high of $616.00. The firm's 50 day moving average price is $521.99 and its 200 day moving average price is $539.16.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the business earned $1.50 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Citigroup reissued a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Royal Bank of Canada dropped their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $596.05.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Chilton Capital Management LLC raised its holdings in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 43 shares during the period. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. Global Financial Private Client LLC raised its holdings in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the period. Finally, Elite Financial Inc. bought a new stake in Intuitive Surgical during the 1st quarter valued at $26,000. Institutional investors and hedge funds own 83.64% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.